Soft Tissue Sarcoma Trials
Trial Name
Subtype
Agents
Phase
Status
Sponsor
Metastatic Leiomyosarcoma (LMS)
Lurbinectedin + doxorubicin
IIb/III
Open, recruiting
PharmaMar
Advanced or metastatic Soft Tissue Sarcoma
Onfekafusp alfa (L19TNF) + Doxorubicin vs. Doxorubicin alone
III
Open, recruiting
Philogen S.p.A.
Soft Tissue Sarcoma
M2554
I
Open, recruiting
EMD Serono Research & Development Institute, Inc.
Synovial sarcoma and myxoid/round cell liposarcoma (MRCLS)
DS-2243a
I
Open, recruiting
Daiichi Sankyo
Advanced Pediatric Solid & CNS Tumors
LOXO-292
I/II
Open, recruiting
Loxo Oncology, Inc. (Eli Lilly)
Solid tumors incl. soft tissue sarcomas
AVA6000
I
Open, recruiting
Avacta Life Sciences Ltd.
Advanced solid tumors incl. EHE
IAG933
I
Open, recruiting
Novartis Pharmaceuticals
Epithelioid Sarcoma
Tazemetostat + doxurubicin vs. docurubicin + placebo
III
Open, recruiting
Epizyme Inc.
Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Gene therapy: ADP-A2M
II
Open, recruiting
Adaptimmune
Solid tumors incl. soft tissue and bone sarcomas
TNG462
I/II
Open, recruiting
Tango Therapeutics
Advanced or Metastatic Soft-tissue Sarcoma
Dacarbazine + L19TNF
II
Open, recruiting
Philogen S.p.A.
Extremity Soft Tissue Sarcomas
Preoperative Radiotherapy
II
Open, recruiting
The Netherlands Cancer Center
Solid tumors incl. soft tissue and bone sarcomas
TNG908
I/II
Closed for recruitment
Tango Therapeutics